BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1478 related articles for article (PubMed ID: 23886814)

  • 1. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J; Zhang L; Oudit GY; Lopaschuk GD
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
    Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
    J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
    Henriksen EJ; Prasannarong M
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
    de Cavanagh EM; Inserra F; Ferder L
    Cardiovasc Res; 2011 Jan; 89(1):31-40. PubMed ID: 20819950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4.
    Mori J; Alrob OA; Wagg CS; Harris RA; Lopaschuk GD; Oudit GY
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1103-13. PubMed ID: 23396452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of cardiac glucose metabolism in association to low birth weight: experimental evidence in lambs with left ventricular hypertrophy.
    Wang KC; Lim CH; McMillen IC; Duffield JA; Brooks DA; Morrison JL
    Metabolism; 2013 Nov; 62(11):1662-72. PubMed ID: 23928106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angs (Angiotensins) of the Alternative Renin-Angiotensin System Predict Outcome in Patients With Heart Failure and Preserved Ejection Fraction.
    Binder C; Poglitsch M; Agibetov A; Duca F; Zotter-Tufaro C; Nitsche C; Aschauer S; Kammerlander AA; Oeztuerk B; Hengstenberg C; Mascherbauer J; Bonderman D
    Hypertension; 2019 Aug; 74(2):285-294. PubMed ID: 31230551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.
    Mori J; Basu R; McLean BA; Das SK; Zhang L; Patel VB; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
    Circ Heart Fail; 2012 Jul; 5(4):493-503. PubMed ID: 22705769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
    Keidar S; Kaplan M; Gamliel-Lazarovich A
    Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats.
    Awwad ZM; El-Ganainy SO; ElMallah AI; Khattab MM; El-Khatib AS
    Toxicology; 2019 Dec; 428():152310. PubMed ID: 31629013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.
    Singh KK; Shukla PC; Yanagawa B; Quan A; Lovren F; Pan Y; Wagg CS; Teoh H; Lopaschuk GD; Verma S
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):702-9. PubMed ID: 23317938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of renin-angiotensin system and peroxisome proliferator-activated receptors in alcoholic cardiomyopathy.
    Jing L; Li WM; Zhou LJ; Li S; Kou JJ; Song J
    Alcohol Clin Exp Res; 2008 Nov; 32(11):1999-2007. PubMed ID: 18783396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
    Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin system and experimental heart failure.
    Wollert KC; Drexler H
    Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.